Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis

IMPORTANCE: Neurologic adverse events (NAEs) due to immune checkpoint inhibitors (ICIs) can be fatal but are underexplored. OBJECTIVE: To compare NAEs reported in randomized clinical trials (RCTs) of US Food and Drug Administration–approved ICIs with other forms of chemotherapy and placebo. DATA SOU...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooq, Muhammad Zain, Aqeel, Sheeba Ba, Lingamaneni, Prasanth, Pichardo, Rayli Carolina, Jawed, Aleeza, Khalid, Saad, Banskota, Shristi Upadhyay, Fu, Pingfu, Mangla, Ankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020216/
https://www.ncbi.nlm.nih.gov/pubmed/35438755
http://dx.doi.org/10.1001/jamanetworkopen.2022.7722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020216/
https://www.ncbi.nlm.nih.gov/pubmed/35438755
http://dx.doi.org/10.1001/jamanetworkopen.2022.7722

Ejemplares similares